Results 381 to 390 of about 1,460,561 (425)

Durable Bio‐Based Nanocomposite Coating on Urinary Catheters Prevents Early‐Stage CAUTI‐Associated Pathogenicity

Advanced Materials Interfaces, EarlyView.
A stable bio‐based nanocomposite coating for urinary catheters is developed using a simple, environmentally‐friendly sonochemical process. The coating, integrating antimicrobial, antibiofilm, and antioxidant properties, effectively tackled multiple early‐stage pathogenic factors associated with catheter‐associated urinary tract infections.
Antonio Puertas‐Segura, Kristina Ivanova, Leonardo Martín Pérez, Bzazou El Ouazzani Zine El Abidine, Aleksandra Ivanova, Barış Gökalsın, Gianluca Ciardelli, Tzanko Tzanov   +7 more
wiley   +1 more source

Long term bivalent mRNA vaccine effectiveness against COVID-19 hospitalisations and deaths in Portugal: a cohort study based on electronic health records. [PDF]

BMC Infect Dis
Machado A, Kislaya I, Soares P, Magalhães S, Nunes B, PT-EHR vaccine group.   +5 more
europepmc   +1 more source

Implantable Microarray Patch: Engineering at the Nano and Macro Scale for Sustained Therapeutic Release via Synthetic Biodegradable Polymers

Advanced Materials Technologies, Volume 10, Issue 6, March 18, 2025.
This review focuses on the application of synthetic biodegradable microarray patches (MAPs) in sustained drug delivery. Compared to conventional MAPs which release drugs into the skin in an immediate manner, these implantable MAPs release drugs into skin microcirculation gradually as the biodegradable polymers degrade, thus offering sustained release ...
Li Zhao, Akmal Hidayat Bin Sabri, Mary B. McGuckin, Linlin Li, Zihao Wang, Eneko Larrañeta, Ryan F. Donnelly   +6 more
wiley   +1 more source

One-for-one or one-for-all? Considerations for filovirus vaccine development. [PDF]

PLoS Biol
Marzi A.
europepmc   +1 more source

A Microfluidic Multiplex Sorter for Strain Development

Advanced Materials Technologies, Volume 10, Issue 6, March 18, 2025.
A new multiplex method for high‐throughput screening of yeast strains based on glucoamylase production is presented. Droplets containing single mutant yeast cells are incubated for enzyme production. A sorting platform divides mutants by their high‐ and mid‐activity levels.
Chiara Leal‐Alves, Sebastien Dumont, Zhiyang Deng, Sarah Alkhaldi, Ziuwin Leung, Michelle Oeser, Steve C. C. Shih   +6 more
wiley   +1 more source

Integrating COVID-19 vaccination into routine healthcare: a feasible model for epidemic response at mildmay hospital Uganda. [PDF]

BMC Public Health
Ankunda C, Chandini S, Namasambi S, Irene N, Wana L, Nanono V, Musana FL, Mwaka J, Nakubulwa S, Mulebeke R, Karamagi Y.   +10 more
europepmc   +1 more source

Exploring influenza vaccination determinants through digital participatory surveillance. [PDF]

BMC Public Health
Kelley K, Gozzi N, Mazzoli M, Paolotti D.   +3 more
europepmc   +1 more source

The Effect of SARS-CoV-2 Vaccination on HIV Viral Load in Patients Under Bictegravir/Tenofovir Alafenamide/Emtricitabine Therapy: A Retrospective Observational Study. [PDF]

Healthcare (Basel)
Pipitone G, Ciusa G, Agrenzano S, Di Lorenzo F, Sagnelli C, Cascio A, Iaria C, TheBICivico StudyGroup.   +7 more
europepmc   +1 more source

Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity. [PDF]

PLoS Negl Trop Dis
Saucha CVV, Maia MLS, Sousa ESS, de Oliveira PMN, Xavier JR, de Castro TDM, Cruz RLS, Schwarcz WD, Pereira RC, Azevedo AS, de Filippis AMB, Ferroco CLV, Pizzini GLC, Brum RCS, Secundino L, Andrade MFS, de Oliveira RVC, Simões M, Cerbino-Neto J, Martins-Filho OA, Campi-Azevedo AC, de Lima SMB, Camacho LAB, Collaborative Group for Yellow Fever Vaccine Studies.   +23 more
europepmc   +1 more source